Wound Care - Sweden

  • Sweden
  • The Wound Care market market in Sweden is projected to generate a revenue of US$31.10m SEK in 2024.
  • It is anticipated to experience an annual growth rate of 0.45% (CAGR 2024-2029).
  • When compared to other countries worldwide, the in the United States is the leading revenue generator with US$1,052.00m SEK in 2024.
  • In terms of per capita revenues, each person in Sweden is expected to contribute US$2.91 SEK to the market in 2024.
  • The demand for advanced wound care products in Sweden is rapidly growing due to the country's aging population and focus on healthcare innovation.

Key regions: Europe, United Kingdom, United States, Japan, Canada

 
Market
 
Region
 
Region comparison
 
Currency
 

Analyst Opinion

The Wound Care market in Sweden has been experiencing steady growth in recent years. Customer preferences have shifted towards advanced wound care products, leading to an increased demand for innovative solutions. Additionally, local special circumstances, such as an aging population and a high prevalence of chronic wounds, have contributed to the growth of the market. Customer preferences in the Wound Care market in Sweden have evolved to prioritize advanced wound care products. This shift can be attributed to several factors, including the increasing awareness of the benefits of advanced wound care solutions and the desire for faster and more effective wound healing. Customers are now seeking products that offer superior wound management, such as antimicrobial dressings and negative pressure wound therapy systems. This preference for advanced wound care products has driven the market towards innovation and the development of new technologies.The market trends in Sweden indicate a growing demand for products that promote faster wound healing and reduce the risk of infection. This is driven by the increasing prevalence of chronic wounds, such as diabetic foot ulcers and pressure ulcers, which require specialized care. As a result, there is a rising need for advanced wound care solutions that can effectively address these specific wound types. Additionally, the market is witnessing a shift towards outpatient wound care, with an emphasis on home-based treatments. This trend is driven by the desire to reduce healthcare costs and improve patient convenience.In Sweden, there are several local special circumstances that contribute to the growth of the Wound Care market. The country has an aging population, which is more susceptible to chronic wounds and requires specialized wound care. Additionally, Sweden has a high prevalence of diabetes, which increases the risk of developing diabetic foot ulcers. These factors create a significant demand for wound care products and services. Furthermore, Sweden has a well-developed healthcare system that provides access to advanced wound care treatments, further driving the market growth.Underlying macroeconomic factors also play a role in the development of the Wound Care market in Sweden. The country has a strong economy and a high level of healthcare expenditure, which enables the adoption of advanced wound care technologies and products. Additionally, Sweden has a well-established regulatory framework that ensures the safety and efficacy of wound care products. This regulatory environment fosters innovation and supports the growth of the market.In conclusion, the Wound Care market in Sweden is experiencing growth due to customer preferences for advanced wound care products, the increasing prevalence of chronic wounds, local special circumstances such as an aging population, and underlying macroeconomic factors. The market trends indicate a shift towards innovative solutions that promote faster wound healing and reduce the risk of infection. With a well-developed healthcare system and a strong economy, Sweden is poised to continue its growth in the Wound Care market.

Methodology

Data coverage:

Data encompasses B2C spend. Figures are based on the OTC Pharmaceuticals market values, representing revenues generated by both product sales which take place exclusively in pharmacies and products which can be purchased elsewhere. Sales by hospitals are not included.

Modeling approach / Market size:

Market sizes are determined by a combined top-down and bottom-up approach, based on a specific rationale for each market market. As a basis for evaluating markets, we use data from national statistical offices, international institutions, trade associations, and self-medication associations. Next, we use relevant key market indicators and data from country-specific associations, such as consumer healthcare spending, out-of-pocket healthcare expenditure, health system accessibilities, and GDP. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. Whereas this market covers only OTC drugs, the Statista Pharmaceuticals market covers both OTC and prescription drugs.

Overview

  • Revenue
  • Analyst Opinion
  • Global Comparison
  • Methodology
  • Key Market Indicators
Please wait

Contact

Get in touch with us. We are happy to help.
Statista Locations
Contact Meredith Alda
Meredith Alda
Sales Manager– Contact (United States)

Mon - Fri, 9am - 6pm (EST)

Contact Yolanda Mega
Yolanda Mega
Operations Manager– Contact (Asia)

Mon - Fri, 9am - 5pm (SGT)

Contact Kisara Mizuno
Kisara Mizuno
Senior Business Development Manager– Contact (Asia)

Mon - Fri, 10:00am - 6:00pm (JST)

Contact Lodovica Biagi
Lodovica Biagi
Director of Operations– Contact (Europe)

Mon - Fri, 9:30am - 5pm (GMT)

Contact Carolina Dulin
Carolina Dulin
Group Director - LATAM– Contact (Latin America)

Mon - Fri, 9am - 6pm (EST)